Journey in Pictures
Main Menu
- Presentations / PDFs
- Conference Presentations
- Reference Documents
- Dr. Baum NorCal CarciNET march 2011 theranostics
- bushnellbaum 2011 endocrinol metab clin north america standard imaging techniques for net
- changing role of somatostatin receptor targeted drugs
- differential_therapy_for_neuroendocrine_tumors
- kaemmerer_2011_ejnmmi_molecular imaging with 68ga-sstr petct and correlation to immunohistochemistry of sstr in net
- kolenc-peitl_2011_j med chem_highly improved in-111-dota-gastrin conjugates
- kwekkeboom_2008_jco_treatment with lu-tate - toxicity efficacy and survival
- local_interventional_therapy_options_for_neuroendocrine_tumors_net
- multi-modal_diagnosis_and_treatment_of_neuroendocrine_tumors__complexity
- prrnt guidelines
- prrt for nets - kwekkeboom et. al
- roesch-baum_2011_dalton transactions_generator-based radiopharmaceuticals
- secondannouncement_worldcongress_ga-68-1
- tourguide-weimar
- CNETs Singapore Survey on MisDx
- G868 Open Meeting SNMMI Vancouver Meeting
- WARMTH Release Regard Dr. Padhy
- Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) for Neuroendocrine Tumours
- Ga68 - Towards Approval in the US
- How smart is peptide receptor radionuclide therapy
- PRRT - Facts and Myths
- PRRT and Sirspheres - German Expereince
- NETTER-1
- Phase II Study - Safety Lu 177 Buam
- Prostate
- Baum et al_2015_NM_Theranostik des metastasierten Prostatakarzinoms mittels Lu-177 PSMA-Liganden in Kombination mit Ga-68 PSMA PETCT
- Baum_2016_JNMMI_Lu-177 Labeled PSMA Radioligand Therapy of mCRPC - Safety and Efficacy
- Eiber-Baum_Editorial_Prostatakarzinom- Bildgebung und Therapie im Wandel
- Kratochwil_2016_JNMMI_225Ac-PSMA-617 for PSMA targeting alpha-radiation therapy of patients with metastatic castration-resistant prostate cancer
- Kulkarni&Baum_2016_JNMMI_PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer - The Bad Berka Experience Since 2013
- Maina_2015_EJNMMI_Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PETCT
- Rahbar_2016_JNMMI_German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients
- Rai_2016_Urology_The Role of PET With Ga-68 PSMA in the Management of Patients
- Weineisen_2015_JNMMI_Ga-68 and Lu-177 labeled PSMA I&T
- Site Map
- Home
- Welcome to PRRTinfo.org
- Lutathera Approved in the European Union
- Lutathera Expanded Access Program In U.S.
- Results from NETTER-1 PRRT Trail Released
- Breaking News - Theranostics for Prostate
- Understanding Dosimetry
- 2014 SNMMI Patient Education Day
- Updates from the Ga68 Working Group
- Ga68 Pet/CT Map
- Ga68 - Orphan Drug Announcement
- IAEA Guidance on PRRNT for NETs
- Presentations from the 2nd World Congress on Ga68
- PRRT Multi-Center Trial Now Open
- PRRT
- Zentralklinik Bad Berka
- Patient Info
- Patient Stories
- PRRT News
- Resources / Links
- Calendar of Events
- Journey in Pictures
- FAQs
- About this site
- Login
Patient Info
- Patient Info Home
- Home
- Evaluation Information
- Traveling to Bad Berka
- Visiting Weimar
- Overview of Clinic Stay
- In Clinic Tests and Scans
- PRRT Treatment Process
- Post Treatment / Returning Home
- Understanding Costs and Insurance
- Journey in Pictures